Liminal BioSciences Inc. Debt to Equity Ratio 2017-2023 | LMNL
Current and historical debt to equity ratio values for Liminal BioSciences Inc. (LMNL) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Liminal BioSciences Inc. debt/equity for the three months ending June 30, 2023 was .
Debt/Equity Ratio Historical Data |
Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
2023-06-30 |
$0.01B |
$0.02B |
0.48 |
2023-03-31 |
$0.01B |
$0.02B |
0.35 |
2022-12-31 |
$0.01B |
$0.03B |
0.39 |
2022-09-30 |
$0.01B |
$0.03B |
0.33 |
2022-06-30 |
$0.04B |
$0.01B |
3.02 |
2022-03-31 |
$0.04B |
$0.02B |
2.31 |
2021-12-31 |
$0.07B |
$0.03B |
2.72 |
2021-09-30 |
$0.08B |
$0.04B |
2.09 |
2021-06-30 |
$0.09B |
$-0.03B |
-3.19 |
2021-03-31 |
$0.08B |
$-0.00B |
-20.13 |
2020-12-31 |
$0.08B |
$0.01B |
6.85 |
2020-09-30 |
$0.07B |
$0.02B |
3.28 |
2020-06-30 |
$0.05B |
$0.03B |
1.44 |
2020-03-31 |
$0.05B |
$0.05B |
0.90 |
2019-12-31 |
$0.05B |
$0.07B |
0.74 |
2019-09-30 |
$0.06B |
$0.08B |
0.71 |
2019-06-30 |
$0.05B |
$0.10B |
0.53 |
2019-03-31 |
$0.17B |
$-0.06B |
-2.67 |
2018-12-31 |
$0.13B |
$-0.05B |
-2.63 |
2018-09-30 |
$0.15B |
$0.05B |
3.16 |
2018-06-30 |
$0.14B |
$0.07B |
1.96 |
2018-03-31 |
$0.13B |
$0.10B |
1.33 |
2017-12-31 |
$0.11B |
$0.11B |
0.98 |
2017-09-30 |
$0.10B |
$0.14B |
0.70 |
2017-06-30 |
$0.09B |
$0.10B |
0.94 |
2017-03-31 |
$0.08B |
$0.12B |
0.65 |
2016-12-31 |
$0.08B |
$0.12B |
0.67 |
2016-09-30 |
$0.07B |
$0.11B |
0.62 |
2016-06-30 |
$0.07B |
$0.14B |
0.48 |
2016-03-31 |
$0.07B |
$0.10B |
0.65 |